Aptus Pharma Limited (BOM:544529)

Aptus Pharma Statistics

Total Valuation

Aptus Pharma has a market cap or net worth of INR 3.08 billion. The enterprise value is 3.15 billion.

Market Cap	3.08B
Enterprise Value	3.15B

Important Dates

The last earnings date was Monday, April 27, 2026.

Earnings Date	Apr 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Aptus Pharma has 17.15 million shares outstanding. The number of shares has increased by 295.83% in one year.

Current Share Class	17.15M
Shares Outstanding	17.15M
Shares Change (YoY)	+295.83%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	72.89%
Owned by Institutions (%)	6.38%
Float	3.69M

Valuation Ratios

The trailing PE ratio is 57.78.

PE Ratio	57.78
Forward PE	n/a
PS Ratio	6.62
PB Ratio	13.21
P/TBV Ratio	13.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 42.23, with an EV/FCF ratio of -34.77.

EV / Earnings	68.08
EV / Sales	6.75
EV / EBITDA	42.23
EV / EBIT	44.68
EV / FCF	-34.77

Financial Position

The company has a current ratio of 1.83, with a Debt / Equity ratio of 0.31.

Current Ratio	1.83
Quick Ratio	1.02
Debt / Equity	0.31
Debt / EBITDA	0.96
Debt / FCF	-0.79
Interest Coverage	8.82

Financial Efficiency

Return on equity (ROE) is 30.48% and return on invested capital (ROIC) is 22.65%.

Return on Equity (ROE)	30.48%
Return on Assets (ROA)	13.44%
Return on Invested Capital (ROIC)	22.65%
Return on Capital Employed (ROCE)	29.05%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	6.65M
Profits Per Employee	659,986
Employee Count	70
Asset Turnover	1.42
Inventory Turnover	2.07

Taxes

In the past 12 months, Aptus Pharma has paid 17.55 million in taxes.

Income Tax	17.55M
Effective Tax Rate	27.53%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	134.45
200-Day Moving Average	n/a
Relative Strength Index (RSI)	75.59
Average Volume (20 Days)	20,750

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aptus Pharma had revenue of INR 465.75 million and earned 46.20 million in profits. Earnings per share was 3.11.

Revenue	465.75M
Gross Profit	252.05M
Operating Income	70.39M
Pretax Income	63.75M
Net Income	46.20M
EBITDA	74.47M
EBIT	70.39M
Earnings Per Share (EPS)	3.11

Balance Sheet

The company has 10.27 million in cash and 71.82 million in debt, with a net cash position of -61.55 million or -3.59 per share.

Cash & Cash Equivalents	10.27M
Total Debt	71.82M
Net Cash	-61.55M
Net Cash Per Share	-3.59
Equity (Book Value)	233.46M
Book Value Per Share	13.68
Working Capital	159.30M

Cash Flow

In the last 12 months, operating cash flow was -68.60 million and capital expenditures -21.87 million, giving a free cash flow of -90.46 million.

Operating Cash Flow	-68.60M
Capital Expenditures	-21.87M
Depreciation & Amortization	4.08M
Net Borrowing	-31.78M
Free Cash Flow	-90.46M
FCF Per Share	-5.27

Margins

Gross margin is 54.12%, with operating and profit margins of 15.11% and 9.92%.

Gross Margin	54.12%
Operating Margin	15.11%
Pretax Margin	13.69%
Profit Margin	9.92%
EBITDA Margin	15.99%
EBIT Margin	15.11%
FCF Margin	n/a

Dividends & Yields

Aptus Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-295.83%
Shareholder Yield	-295.83%
Earnings Yield	1.50%
FCF Yield	-2.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 12, 2026. It was a forward split with a ratio of 2.5.

Last Split Date	May 12, 2026
Split Type	Forward
Split Ratio	2.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	3